Albin Rudisch
Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Cancer Research and Treatments, Growth Hormone and Insulin-like Growth Factors, Antifungal resistance and susceptibility, Cellular Mechanics and Interactions
Most-Cited Works
- → Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery(2016)241 cited
- → Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression(2017)140 cited
- → IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction(2014)119 cited
- → Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms(2017)84 cited
- → High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts(2015)42 cited
- → Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus(2004)25 cited
- → Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells(2020)9 cited
- → Abstract 630: Co-injection of human fibroblasts significantly enhances tumorigenicity of orthotopically implanted human non-small cell lung cancer cells in immunocompromised mice(2016)1 cited
- → Ankündigung(1996)
- → Tumor Mikrozirkulation und Diffusionskoeffizienten als Prognoseparameter bei primären Rektumkarzinomen(2004)